Spruce BiosciencesSPRB
13F holders, Q2 2025 (June 30)3holders −28
0new positions
29sold out
$0.07avg. 13F price*
At the end of Q2 2025, 3 institutions reported holding Spruce Biosciences Inc. (SPRB) in their 13F filings, down 28 from Q1 2025. 0 opened new positions and 29 sold out. The largest holders were Acadian Asset Management LLC ($74K), Ikarian Capital, LLC ($73K) and Caldwell Sutter Capital, Inc. ($73).
- Company
- Spruce Biosciences Inc.
- CUSIP
- 85209E109
- Latest filing quarter
- Q2 2025
History
Number of 13F holders
Total Exit/New Position Q1 2025 → Q2 2025
| Institutions | Total Value | |
|---|---|---|
| New Positions | 0 | $0 |
| Exits | 29 | $2.4M |
All 13F filers, Q1 2025 → Q2 2025: 8,404,772 shares sold, net −8,404,772 shares. Counts holders who added, trimmed, opened or closed a position; split-adjusted.
Ownership 3 holders
| Acadian Asset Management LLC | 0.00% | No change | 1,045,828 | $74K |
| Ikarian Capital, LLC | 0.02% | No change | 1,000,000 | $73K |
| Caldwell Sutter Capital, Inc. | 0.00% | No change | 1,000 | $73 |
"% of holder's portfolio" is SPRB's weight in each manager's 13F, not the share of Spruce Biosciences Inc. the manager owns.